Breathe It In
The potential of inhaled drug delivery goes beyond traditional respiratory medicine.
Simon Moore |
Historically, inhaled drugs have targeted the main respiratory diseases, namely asthma and chronic obstructive pulmonary disease. Inhaled drug delivery, however, has a number of inherent advantages that can also benefit other therapeutic areas. Compared with oral drugs, for example, inhaled medicines avoid first-pass metabolism and degradation in the GI tract. Inhaled drugs also often require lower dose levels and usually provide faster onset of action (1). And when it comes to comparison with parenterals, inhaled drugs are less intrusive and provide improved stability, especially for proteins and peptides (2).
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.